Study of Efficacy and Safety of ABO809 in Healthy Participants

Clinical trial NCT05036668 · COMPLETED

Trial details

NCT number: NCT05036668
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cryptosporidium Infection, Cryptosporidiosis

Start date: 2022-04-07
Primary completion: 2022-11-07
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.